Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

Abstract

Leber congenital amaurosis type 10 is a severe retinal dystrophy caused by mutations in the CEP290 gene 1,2 . We developed EDIT-101, a candidate genome-editing therapeutic, to remove the aberrant splice donor created by the IVS26 mutation in the CEP290 gene and restore normal CEP290 expression. Key to this therapeutic, we identified a pair of Staphylococcus aureus Cas9 guide RNAs that were highly active and specific to the human CEP290 target sequence. In vitro experiments in human cells and retinal explants demonstrated the molecular mechanism of action and nuclease specificity. Subretinal delivery of EDIT-101 in humanized CEP290 mice showed rapid and sustained CEP290 gene editing. A comparable surrogate non-human primate (NHP) vector also achieved productive editing of the NHP CEP290 gene at levels that met the target therapeutic threshold, and demonstrated the ability of CRISPR/Cas9 to edit somatic primate cells in vivo. These results support further development of EDIT-101 for LCA10 and additional CRISPR-based medicines for other inherited retinal disorders.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0327-9

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 33 references

Cited by

See all 759

Metadata

Authors
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., Dass, A., Dhanapal, V., Fennell, T. J., Friedland, A. E., Giannoukos, G., Gloskowski, S. W., Glucksmann, A., Gotta, G. M., Jayaram, H., Haskett, S. J., Hopkins, B., Horng, J. E., Joshi, S., Marco, E., Mepani, R., Reyon, D., Ta, T., Tabbaa, D. G., Samuelsson, S. J., Shen, S., Skor, M. N., Stetkiewicz, P., Wang, T., Yudkoff, C., Myer, V. E., Albright, C. F., & Jiang, H.
Affiliations
  • Editas Medicine (United States) (US)
  • Fulcrum Genomics (United States) (US)
Corresponding author
Maeder, Morgan L.
Venue
Nature Medicine
Published
2019-01-21
Volume
25
Issue
2
Pages
229-233
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2908873329
Cited by
707
References
33
Citations by year
2026: 58 · 2025: 84 · 2024: 85 · 2023: 91 · 2022: 117 · 2021: 126 · 2020: 101 · 2019: 44
FWCI
32.52
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
CEP290, CRISPR/Cas9 genome editing, retinal dystrophy, inherited retinal degeneration, humanized mice, subretinal delivery, congenital blindness
MeSH terms
Gene Editing, Animals, Cell Line, Humans, Primates, Vision, Ocular, Reproducibility of Results, Mice, Gene Knock-In Techniques, Leber Congenital Amaurosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. https://app.cochat.ai/papers/10.1038/s41591-018-0327-9
The paper
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., Dass, A., Dhanapal, V., Fennell, T. J., Friedland, A. E., Giannoukos, G., Gloskowski, S. W., Glucksmann, A., Gotta, G. M., Jayaram, H., . . . Jiang, H. (2019). Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nature Medicine. https://doi.org/10.1038/s41591-018-0327-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.